Differential effects of lercanidipine and nifedipine GITS on plasma norepinephrine in chronic treatment of hypertension

American Journal of Hypertension

Volumn 16, Issue 7, 2003, Pages 596-599

  Fogari, Roberto ^a,b   Mugellini, Amedeo ^a   Zoppi, Annalisa ^a   Corradi, Luca ^a   Rinaldi, Andrea ^a   Derosa, Giuseppe ^a   Preti, Paola ^a  

^a UNIVERSITY OF PAVIA   (Italy)

^b FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

Hypertension; Lercanidipine; Nifedipine GITS; Norepinephrine

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; DIHYDROPYRIDINE; LERCANIDIPINE; NIFEDIPINE; NORADRENALIN; PLACEBO;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC VALUE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HEART RATE; HUMAN; HYPERTENSION; MALE; MEDICAL ASSESSMENT; NORADRENALIN BLOOD LEVEL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REDUCTION; REGULATORY MECHANISM; SYMPATHETIC NERVE CELL; SYMPATHETIC TONE;

EID: 0037898376     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-7061(03)00901-4     Document Type: Article

References (19)

1. Lindqvist M, Kahan T, Melcher A, Hjemdahl P: Acute and chronic calcium antagonist treatment elevates sympathetic activity in primary hypertension. Hypertension 1994;24:287-296.
2. Van der Lee R, Kam KL, Pfaffendoff M, Van Zwieten PA: Differential time course of the vasodilation action of various calcium antagonists. Fundam Clin Pharmacol 1998;12:607-612.
3. Mancia G: The sympathetic nervous system in hypertension. Bjorn Folkow Award Lecture. J Hypertens 1997;15:1553-1565.
4. Furberg CD, Psaty BM, Meyer JV: Nifedipine. Dose-related increase in mortality in patients with coronary heart disease. Circulation 1995;92:1326-1331.
5. Grossman E, Messerli FH: Effect of calcium antagonists on plasma norepinephrine levels, heart rate and blood pressure. Am J Cardiol 1997;80:1453-1458.
6. De Champlain J, Karas M, Nguyen P, Cartier P, Wistaff R, Toal CB, Nideau R, Larochelle P: Different effects of nifedipine and amlodipine on circulating catecholamine levels in essential hypertensive patients. J Hypertens 1998;16:1357-1369.
7. Hamada T, Watanabe M, Kaneda T, Ohtahara A, Kinugawa T, Hisatome I, Fujimoto Y, Yoshida A, Shigemasa C: Evaluation of changes in sympathetic nerve activity and heart rate in essential hypertensive patients induced by amlodipine and nifedipine. J Hypertens 1998;16:111-118.
8. Fogari R, Zoppi A, Corradi L, Preti P, Malamani GD, Mugellini A: Effects of different dihydropyridine calcium antagonists on plasma norepinephrine in essential hypertension. J Hypertens 2000;18:1871-1875.
9. Krakoff LR: Effectiveness of nifedipine gastrointestinal therapeutic system for treatment of hypertension: Results of the MATH trial. J Cardiovasc Pharmacol 1993;21(Suppl 2):S14-S17.
10. Herbette LG, Vecchiarelli M, Sartani A, Leonardi A: Lercanidipine: short plasma half-life, long duration of action and high cholesterol tolerance. Updated molecular model to rationalize its pharmacokinetic properties. Blood Press 1998;7(Suppl 2):S10-S17.
11. Rea RF, Eckberg DL, Fritsch JM, Goldstein DS: Relation of plasma norepinephrine and sympathetic traffic during hypotension in humans. Am J Physiol 1990;258:R982-R986.
12. Remie R, Zaagsma J: A new technique for the study of vascular presynaptic receptors in freely moving rats. Heart Circ Physiol 1986;251:4463-4467.
13. Hjemdahl P: Plasma catecholamines as markers for sympathoadrenal activity in human primary hypertension. Pharmacol Toxicol 1988;63(Suppl 1):S27-S31.
14. Kerckhoff W, Drewes LR: Transfer of the calcium-antagonists nifedipine and nimodipine across the blood-brain barrier and their regional distribution in vivo. J Cerebr Blood Metab 1985;5:459-460.
15. Murzenok PP, Huang BS, Leenen FH: Sympathoinhibition by central and peripheral infusion of nifedipine in spontaneously hypertensive rats. Hypertension 2000;35:631-636.
16. Leenen FH, Ruzicka M, Huang BS: Central sympathoinhibitory effects of calcium channel blockers. Curr Hypertens Rep 2001;3:314-321.
17. Wenzel RR, Allegranza G, Binggeli C, Shaw S, Weidman P, Luscher TF, Noll G: Differential activation of cardiac and peripheral sympathetic nervous system by nifedipine: Role of pharmacokinetics. J Am Coll Cardiol 1997;29:1607-1614.
18. Grassi G, Esler M: How to assess sympathetic activity in humans. J Hypertens 1999;17:719-734.
19. Fogari R, Malamani GD, Zoppi A, Preti P, Vanesia A, Fogari E, Mugellini A: Comparative effect of lercanidipine and nifedipine gastrointestinal therapeutic system on ankle volume and subcutaneous interstitial pressure in hypertensive patients: A double-blind, randomized, parallel-group study. Curr Ther Res Clin Exp 2000;61:850-862.